SCHEMBL612301

SCHEMBL612301

Cc1cc(Br)cs1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Formic Acid SCHEMBL29133218 0.85 DAO (0.43)
SCHEMBL18869535 0.73 ALAD (0.52)
SCHEMBL4244577 0.71 DAO (0.44)
SCHEMBL40746 0.71
SCHEMBL19357535 0.67
SCHEMBL5004859 0.67
SCHEMBL771882 0.67 CES2 (0.43)
SCHEMBL422305 0.67
SCHEMBL2016588 0.67 CES2 (0.43)
SCHEMBL2679589 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 586 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116554009-A Electrophilic cross-coupling reaction method of aryl sulfone or heteroaryl sulfone and aryl bromide 南京工业大学 2023-08-08 CN claimed
CN-110117270-B Preparation method of 3- (thiophene-2-yl) cyclohexanone framework compound 山西大学 2021-07-27 CN claimed
US-20150291623-A1 SPIRO-OXINDOLE COMPOUNDS AND THEIR USE AS THERAPEUTIC AGENTS XENON PHARMACEUTICALS INC. (CA) 2015-10-15 US claimed
US-20120295897-A1 SPIRO-OXINDOLE COMPOUNDS AND THEIR USES AS THERAPEUTIC AGENTS XENON PHARMACEUTICALS INC. (CA) 2012-11-22 US claimed
CN-102256983-A Spirooxindole compounds and their use as therapeutic agents XENON PHARMACEUTICALS INC 2011-11-23 CN claimed
EP-2350090-A2 SPIRO-OXINDOLE COMPOUNDS AND THEIR USE AS THERAPEUTIC AGENTS Xenon Pharmaceuticals Inc. (CA) 2011-08-03 EP claimed
US-20100137299-A1 SPIRO-OXINDOLE COMPOUNDS AND THEIR USE AS THERAPEUTIC AGENTS XENON PHARMACEUTICALS INC. (CA) 2010-06-03 US claimed
WO-2010045251-A2 SPIRO-OXINDOLE COMPOUNDS AND THEIR USE AS THERAPEUTIC AGENTS XENON PHARMACEUTICALS, INC. (CA) 2010-04-22 WO claimed
WO-2007017728-A2 NOVEL HETEROCYCLIC COMPOUNDS ORCHID RESEARCH LABORATORIES LIMITED (IN) 2007-02-15 WO claimed
US-20040014764-A1 N-myristoyltransferase inhibitor compositions and methods of use SMITH CHARLES D (US) 2004-01-22 US claimed
CN-122070275-A Heterocyclic compound and application thereof 成都麻沸散医药科技有限公司 2026-05-19 CN disclosed
CN-122010938-A Pyrido [1, 2-a ] pyrimidine mesoionic derivative containing five-membered heterocyclic structure, and preparation and application thereof 贵州大学 2026-05-12 CN disclosed
EP-4725493-A2 POLYCYCLIC COMPOUNDS FOR INHIBITING RNA HELICASE DHX33 AND USE THEREOF Shenzhen Keye Life Technologies, Co., Ltd. (CN) 2026-04-15 EP disclosed
US-20260034101-A1 ANTIMITOTIC AMIDES FOR THE TREATMENT OF CANCER AND PROLIFERATIVE DISORDERS FROST BIOLOGIC INC (US) 2026-02-05 US disclosed
EP-3889133-B1 4-[[2-[[5-[1-(1H-INDOL-2-YL)-2-(PHENYL)-1-ETHEN-1-YL]-2-PYRIDINYL]OXY]ETHYL]AMINO]-2-BUTENAMIDE DERIVATIVES FOR THE TREATMENT OF ESTROGEN RECEPTOR POSITIVE BREAST CANCER CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD (CN) 2026-01-28 EP disclosed
EP-0196001-B1 THIOPHENE RING-SUBSTITUTED ALPHA-(ALKYLAMINOPROPIONYL)-THIOPHENE DERIVATIVES, A PROCESS FOR PREPARING THEM AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM FERRER INTERNACIONAL, S.A. (ES) 1989-01-25 EP disclosed
EP-0247381-A2 5-flurorouracil derivatives OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1987-12-02 EP disclosed
EP-0196001-A1 Thiophene ring-substituted alpha-(alkylaminopropionyl)-thiophene derivatives, a process for preparing them and pharmaceutical compositions containing them FERRER INTERNACIONAL, S.A. (ES) 1986-10-01 EP disclosed
US-4535092-A Acylanilides having antiandrogenic activity IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1985-08-13 US disclosed
EP-0079191-A1 Amide derivatives IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1983-05-18 EP disclosed